Antibody Drug
- All
- News
- Videos
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
- Thursday December 11, 2025
- Offbeat | Edited by Ritu Singh
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
www.ndtv.com
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
- Monday September 25, 2023
- World News | Edited by Ritu Singh
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
www.ndtv.com
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
- Wednesday June 8, 2022
- Science | Press Trust of India
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
www.ndtv.com
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
- Tuesday January 18, 2022
- India News | Asian News International
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
www.ndtv.com
-
2 New Medicines For Covid Treatment Get WHO Approval
- Friday January 14, 2022
- World News | Marthe Fourcade, Bloomberg
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
www.ndtv.com
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
- Tuesday November 9, 2021
- World News | Reuters
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
www.ndtv.com
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
- Thursday September 2, 2021
- World News | Agence France-Presse
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
www.ndtv.com
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
- Friday August 20, 2021
- World News | Suzi Ring, Bloomberg
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
www.ndtv.com
-
Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study
- Wednesday June 16, 2021
- World News | Agence France-Presse
A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.
-
www.ndtv.com
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
- Thursday December 11, 2025
- Offbeat | Edited by Ritu Singh
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
www.ndtv.com
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
- Monday September 25, 2023
- World News | Edited by Ritu Singh
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
www.ndtv.com
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
- Wednesday June 8, 2022
- Science | Press Trust of India
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
www.ndtv.com
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
- Tuesday January 18, 2022
- India News | Asian News International
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
www.ndtv.com
-
2 New Medicines For Covid Treatment Get WHO Approval
- Friday January 14, 2022
- World News | Marthe Fourcade, Bloomberg
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
www.ndtv.com
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
- Tuesday November 9, 2021
- World News | Reuters
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
www.ndtv.com
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
- Thursday September 2, 2021
- World News | Agence France-Presse
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
www.ndtv.com
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
- Friday August 20, 2021
- World News | Suzi Ring, Bloomberg
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
www.ndtv.com
-
Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study
- Wednesday June 16, 2021
- World News | Agence France-Presse
A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.
-
www.ndtv.com